These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25461324)

  • 1. Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.
    Cai H; Liu Q; Gao D; Wang T; Chen T; Yan G; Chen K; Xu Y; Wang H; Li Y; Zhu W
    Eur J Med Chem; 2015 Jan; 90():241-50. PubMed ID: 25461324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Virtual Screening and Substructure Search for Discovery of Novel FABP4 Inhibitors.
    Cai H; Wang T; Yang Z; Xu Z; Wang G; Wang HY; Zhu W; Chen K
    J Chem Inf Model; 2017 Sep; 57(9):2329-2335. PubMed ID: 28810126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule inhibitors of human adipocyte fatty acid binding protein (FABP4).
    Zhang M; Zhu W; Li Y
    Med Chem; 2014 Jun; 10(4):339-47. PubMed ID: 24024500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review.
    Floresta G; Pistarà V; Amata E; Dichiara M; Marrazzo A; Prezzavento O; Rescifina A
    Eur J Med Chem; 2017 Sep; 138():854-873. PubMed ID: 28738306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new dual FABP4/5 inhibitors based on a naphthalene-1-sulfonamide FABP4 inhibitor.
    He Y; Dou H; Gao D; Wang T; Zhang M; Wang H; Li Y
    Bioorg Med Chem; 2019 Oct; 27(19):115015. PubMed ID: 31420256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4.
    Gao DD; Dou HX; Su HX; Zhang MM; Wang T; Liu QF; Cai HY; Ding HP; Yang Z; Zhu WL; Xu YC; Wang HY; Li YX
    Eur J Med Chem; 2018 Jun; 154():44-59. PubMed ID: 29775936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity.
    Lan H; Cheng CC; Kowalski TJ; Pang L; Shan L; Chuang CC; Jackson J; Rojas-Triana A; Bober L; Liu L; Voigt J; Orth P; Yang X; Shipps GW; Hedrick JA
    J Lipid Res; 2011 Apr; 52(4):646-56. PubMed ID: 21296956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.
    Cai H; Yan G; Zhang X; Gorbenko O; Wang H; Zhu W
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3675-9. PubMed ID: 20471252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice.
    Cai HY; Wang T; Zhao JC; Sun P; Yan GR; Ding HP; Li YX; Wang HY; Zhu WL; Chen KX
    Acta Pharmacol Sin; 2013 Nov; 34(11):1397-402. PubMed ID: 24077632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of FDA-approved drugs as inhibitors of fatty acid binding protein 4 using molecular docking screening.
    Wang Y; Law WK; Hu JS; Lin HQ; Ip TM; Wan DC
    J Chem Inf Model; 2014 Nov; 54(11):3046-50. PubMed ID: 25360897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation.
    Zhou Y; Nie T; Zhang Y; Song M; Li K; Ding M; Ding K; Wu D; Xu Y
    Bioorg Med Chem; 2016 Sep; 24(18):4310-4317. PubMed ID: 27460668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins.
    Hertzel AV; Hellberg K; Reynolds JM; Kruse AC; Juhlmann BE; Smith AJ; Sanders MA; Ohlendorf DH; Suttles J; Bernlohr DA
    J Med Chem; 2009 Oct; 52(19):6024-31. PubMed ID: 19754198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing.
    Suhre K; Römisch-Margl W; de Angelis MH; Adamski J; Luippold G; Augustin R
    J Biomol Screen; 2011 Jun; 16(5):467-75. PubMed ID: 21543640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-Based Screening.
    Zhou Y; Elmes MW; Sweeney JM; Joseph OM; Che J; Hsu HC; Li H; Deutsch DG; Ojima I; Kaczocha M; Rizzo RC
    Biochemistry; 2019 Oct; 58(42):4304-4316. PubMed ID: 31539229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms.
    Mita T; Furuhashi M; Hiramitsu S; Ishii J; Hoshina K; Ishimura S; Fuseya T; Watanabe Y; Tanaka M; Ohno K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
    Obesity (Silver Spring); 2015 Feb; 23(2):359-67. PubMed ID: 25521833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.
    Floresta G; Gentile D; Perrini G; Patamia V; Rescifina A
    Mar Drugs; 2019 Oct; 17(11):. PubMed ID: 31683588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
    Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K
    J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.
    Szilágyi B; Skok Ž; Rácz A; Frlan R; Ferenczy GG; Ilaš J; Keserű GM
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1693-1698. PubMed ID: 29699925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors.
    Kühne H; Obst-Sander U; Kuhn B; Conte A; Ceccarelli SM; Neidhart W; Rudolph MG; Ottaviani G; Gasser R; So SS; Li S; Zhang X; Gao L; Myers M
    Bioorg Med Chem Lett; 2016 Oct; 26(20):5092-5097. PubMed ID: 27658368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia pneumoniae exploits adipocyte lipid chaperone FABP4 to facilitate fat mobilization and intracellular growth in murine adipocytes.
    Walenna NF; Kurihara Y; Chou B; Ishii K; Soejima T; Itoh R; Shimizu A; Ichinohe T; Hiromatsu K
    Biochem Biophys Res Commun; 2018 Jan; 495(1):353-359. PubMed ID: 29108997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.